Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Next-Generation Sequencing in Medicine (Upcoming)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

CorrigendumDermatology Free access | 10.1172/JCI38543C1

A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans

Anna Mandinova, Vihren Kolev, Victor Neel, Bing Hu, Wesley Stonely, Jocelyn Lieb, Xunwei Wu, Claudia Colli, Rong Han, Michael J. Pazin, Paola Ostano, Reinhard Dummer, Janice L. Brissette, and G. Paolo Dotto

Find articles by Mandinova, A. in: JCI | PubMed | Google Scholar

Find articles by Kolev, V. in: JCI | PubMed | Google Scholar

Find articles by Neel, V. in: JCI | PubMed | Google Scholar

Find articles by Hu, B. in: JCI | PubMed | Google Scholar

Find articles by Stonely, W. in: JCI | PubMed | Google Scholar

Find articles by Lieb, J. in: JCI | PubMed | Google Scholar

Find articles by Wu, X. in: JCI | PubMed | Google Scholar

Find articles by Colli, C. in: JCI | PubMed | Google Scholar

Find articles by Han, R. in: JCI | PubMed | Google Scholar

Find articles by Pazin, M. in: JCI | PubMed | Google Scholar

Find articles by Ostano, P. in: JCI | PubMed | Google Scholar

Find articles by Dummer, R. in: JCI | PubMed | Google Scholar

Find articles by Brissette, J. in: JCI | PubMed | Google Scholar

Find articles by Dotto, G. in: JCI | PubMed | Google Scholar

Published February 1, 2010 - More info

Published in Volume 120, Issue 2 on February 1, 2010
J Clin Invest. 2010;120(2):645–645. https://doi.org/10.1172/JCI38543C1.
© 2010 The American Society for Clinical Investigation
Published February 1, 2010 - Version history
View PDF

Related article:

A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans
Anna Mandinova, … , Janice L. Brissette, G. Paolo Dotto
Anna Mandinova, … , Janice L. Brissette, G. Paolo Dotto
Research Article Dermatology

A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans

  • Text
  • PDF
Abstract

Seborrheic keratoses (SKs) are common, benign epithelial tumors of the skin that do not, or very rarely, progress into malignancy, for reasons that are not understood. We investigated this by gene expression profiling of human SKs and cutaneous squamous cell carcinomas (SCCs) and found that several genes previously connected with keratinocyte tumor development were similarly modulated in SKs and SCCs, whereas the expression of others differed by only a few fold. In contrast, the tyrosine kinase receptor FGF receptor–3 (FGFR3) and the transcription factor forkhead box N1 (FOXN1) were highly expressed in SKs, and close to undetectable in SCCs. We also showed that increased FGFR3 activity was sufficient to induce FOXN1 expression, counteract the inhibitory effect of EGFR signaling on FOXN1 expression and differentiation, and induce differentiation in a FOXN1-dependent manner. Knockdown of FOXN1 expression in primary human keratinocytes cooperated with oncogenic RAS in the induction of SCC-like tumors, whereas increased FOXN1 expression triggered the SCC cells to shift to a benign SK-like tumor phenotype, which included increased FGFR3 expression. Thus, we have uncovered a positive regulatory loop between FGFR3 and FOXN1 that underlies a benign versus malignant skin tumor phenotype.

Authors

Anna Mandinova, Vihren Kolev, Victor Neel, Bing Hu, Wesley Stonely, Jocelyn Lieb, Xunwei Wu, Claudia Colli, Rong Han, Mike Pazin, Paola Ostano, Reinhard Dummer, Janice L. Brissette, G. Paolo Dotto

×

Original citation: J. Clin. Invest.2009;119(10):3127–3137. doi:10.1172/JCI38543.

Citation for this corrigendum: J. Clin. Invest.2010;120(2):645. doi:10.1172/JCI38543C1.

During the preparation of this manuscript, Michael J. Pazin's name was inadvertently presented incorrectly in the author list. The correct author list appears above.

Michael J. Pazin's support information was inadvertently omitted from the Acknowledgments. The correct Acknowledgments section appears below.

We thank W. Austen for human skin material, D. Prowse for the FOXN1-ER retrovirus, D. Ornitz for FGFR3 constructs, and V. Rajashekara for skillful technical help. This work was supported by NIH grants AR39190, AR054856, AR045284, CA16038, and CA73796; by the Swiss National Foundation; by a grant from the European Union (Epistem, Sixth Framework Program, LSHB-CT-2005-019067); and in part by the Cutaneous Biology Research Center through the MGH/Shiseido Co. Ltd. Agreement. Michael J. Pazin is currently supported by the Intramural Research Program of the NIH National Institute on Aging.

The authors regret the errors.

Version history
  • Version 1 (February 1, 2010): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts